Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic Cancer

IF 8.9 1区医学

Journal of Cachexia, Sarcopenia and Muscle Pub Date : 2024-11-23 DOI:10.1002/jcsm.13643

Ji Hye Min, Jeong Il Yu, Seong Hyun Kim, Young Kon Kim, Kangpyo Kim, Hee Chul Park, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Ho Choi, Jin Seok Heo, In Woong Han, Hongbeom Kim, Sang Hyun Shin, So Jung Yoon, Sook-young Woo

引用次数: 0

Abstract

Patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) require complex management strategies. This study evaluated the prognostic significance of the perichemotherapy skeletal muscle index (SMI) and carbohydrate antigen 19-9 (CA 19-9) in patients with BRPC or LAPC treated with FOLFIRINOX.

查看原文本刊更多论文

胰腺癌患者接受 FOLFIRINOX 局部治疗后骨骼肌指数的变化与生存率

边界可切除（BR）或局部晚期胰腺癌（LAPC）患者需要复杂的治疗策略。本研究评估了接受 FOLFIRINOX 治疗的边界可切除（BR）或局部晚期胰腺癌患者化疗期间骨骼肌指数（SMI）和碳水化合物抗原 19-9（CA 19-9）的预后意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Cachexia, Sarcopenia and Muscle Medicine-Orthopedics and Sports Medicine

自引率

12.40%

发文量

期刊介绍： The Journal of Cachexia, Sarcopenia, and Muscle is a prestigious, peer-reviewed international publication committed to disseminating research and clinical insights pertaining to cachexia, sarcopenia, body composition, and the physiological and pathophysiological alterations occurring throughout the lifespan and in various illnesses across the spectrum of life sciences. This journal serves as a valuable resource for physicians, biochemists, biologists, dieticians, pharmacologists, and students alike.